Introduction of prostacyclin synthase gene for treatment of cerebral vasospasm
Introduction of prostacyclin synthase gene for treatment of cerebral vasospasm
批准号:
17591500
负责人:
YOSHIDA Takaaki
金额:
$2.31万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
脑血管痉挛是蛛网膜下腔出血的严重并发症,常发生于脑动脉瘤破裂后,但其发病机制尚不清楚。脑血管痉挛是一种独特的临床现象,其特征在于主要脑动脉的延迟和延长收缩。蛛网膜下腔出血引起内皮功能障碍和内皮衍生的舒张因子的抑制。然后,恢复内皮源性舒张因子可以治疗这种现象。内皮源性舒张因子的代表是NO,在实验性SAH模型中导入NO合成酶基因治疗脑血管痉挛。我们关注了另一种内皮源性舒张因子前列环素(PGI 2),并采用等长张力记录法检测了PGI 2(贝前列素钠)的药理作用。贝前列素钠不能抑制高剂量钾(80 mM)引起的收缩。也不能抑制100 μmol/L去甲肾上腺素引起的收缩。贝前列素钠10、100 μmol/L、1 mmol/L可剂量依赖性地抑制10 μmol/LPGF 2 α引起的收缩。然而,贝前列素钠的收缩抑制作用可能不足以治疗SAH后的脑血管痉挛。因此,我们认为导入PGI_2合成酶基因对SAH后严重的脑血管收缩有很大的抑制作用是困难的。PGI_2有可能成为治疗脑血管痉挛的新药物,但仍需进一步研究。
英文摘要
Cerebral vasospasm is a severe complication of subarachnoid hemorrhage that frequently arises after rupture of a cerebral aneurysm, but the pathogenesis is still unclear. Cerebral vasospasm is a unique clinical phenomenon characterized by the delayed and prolonged contraction of the major cerebral arteries. subarachnoid hemorrhage causes dysfunction of endothelium, and inhibition of endothelium-derived relaxing factor. Then, restoration of endothelium derived relaxing factor may treat the phenomenon. The representative endothelium-derived relaxing factor is NO. Introduction of NO synthetase gene treat cerebral vasospasm in experimental SAH model. We paid attention to another endothelium-derived relaxing factor, prostacycline (PGI2), and tested pharmacological effect of PGI2 (beraprost sodium) using isometric tension recording. The beraprost sodium could not inhibit the contraction induced by high dose potassium (80mM). And, that could not inhibit the contraction induced by 100 μmol/L norepinephrine, too. The beraprost sodium 10, 100 μmol/L, 1 mmol/L could inhibit the contraction induced by 10 μmol/L PGF2α, dose-dependently. However, the contractile inhibition effect of beraprost sodium might not be sufficient for the treatment of cerebral vasospasm after SAH. Then, We thought it difficult that introduction of PGI2 synthetase gene had a great inihibitory effect to the severe cerebral vasoconstriction after SAH. PGI2 may have a possibility to be new therapeutic agent for cerebral vasospasm, however the further studies were required.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
IC ligation及びbypass術を施行した海綿静脈洞部内頚動脈瘤の術後MRIの検討
IC结扎搭桥术后海绵状颈内动脉瘤术后MRI检查
DOI:
--
发表时间:
2007
期刊:
日本脳神経CI学会機関誌 CI研究 28巻3-4
影响因子:
--
作者:
[Nakagawa T, et al., Kuwayama N, 桑山直也, 吉田 貴明]
通讯作者:
吉田 貴明
MRI Findings of Carotid Cavernous Aneurysms Treated by IC Ligation and Bypass Surgery
IC结扎搭桥手术治疗颈动脉海绵状动脉瘤的MRI表现
DOI:
--
发表时间:
2007
期刊:
Progress in computed imaging Vol. 28 No. 3-4
影响因子:
--
作者:
[]
通讯作者:
IC ligation及びbypass術を行した海綿静脈洞部頚動脈瘤の術後MRIの検討
颈内动脉海绵状动脉瘤IC结扎搭桥术后MRI检查
DOI:
--
发表时间:
2007
期刊:
日本脳神経CI学会機関誌 CI研究 283-284
影响因子:
--
作者:
[吉田 貴明]
通讯作者:
吉田 貴明
A new model of focal cerabral ischemia in the miniature pig.
小型猪局灶性脑缺血的新模型。
DOI:
--
发表时间:
2006
期刊:
Journal of Neurosurgery 104(2)
影响因子:
--
作者:
[Imai H, etc.]
通讯作者:
etc.
Wave-like appearance of diffuse pachymeningeal enhancement associated with intracranial hypotension.
与颅内低血压相关的弥漫性硬脑膜增强的波状外观。
DOI:
--
发表时间:
2005
期刊:
Neuroradiology 47
影响因子:
--
作者:
[Tosaka M, etc.]
通讯作者:
etc.
共 6 条
海外基金